Page 36 - Adolescent News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Upadacitinib trials in atopic dermatitis have included diverse patient groups with varying risk factors, according to Dr Christopher Bunick.

New data show that psychiatric comorbidities in young people with attention-deficit hyperactivity disorder are associated with an increased schizophrenia risk.

Article: IMAGINING OUR FUTURE: PERILS AND PROMISE: Story 3. Humanity Is Growing Up - If we are to move into our early adulthood as a species and grow beyond our adolescent consciousness, we will need to develop greater capacities to consciously work to restore the resilience and integrity of our Earth's eco-system, consider the impact of our actions on the rest of life (including well as future generations), and bring fresh awareness and sacred regard for the living universe that is our home.

It is the first treatment for pediatric patients with moderate-to-severe atopic dermatitis that specifically targets the interleukin (IL)-13 cytokine.

The US Preventive Services Task Force issued a draft recommendation statement outlining the interventions that should be taken when a child or teen has a high body mass index.